Table S1.
Characteristics | N |
SOX1
|
PAX1
|
||||||
---|---|---|---|---|---|---|---|---|---|
M | U | Methylated percentage | P-value | M | U | Methylated percentage | P-value* | ||
Age, years | 0.239 | 0.560 | |||||||
Mean (SD) [range] | 70 | (11.9) | (36–90) | ||||||
<50 | 15 | 7 | 8 | 46.67 | 3 | 12 | 20.00 | ||
50–70 | 61 | 42 | 19 | 68.85 | 21 | 40 | 34.43 | ||
>70 | 90 | 54 | 36 | 60.00 | 29 | 61 | 32.22 | ||
Gender | 0.631 | 0.617 | |||||||
Male | 83 | 53 | 30 | 63.86 | 28 | 55 | 33.73 | ||
Female | 83 | 50 | 33 | 60.24 | 25 | 58 | 30.12 | ||
M | 0.576 | 0.191 | |||||||
M0 | 142 | 88 | 54 | 61.97 | 43 | 99 | 30.28 | ||
M1 | 24 | 15 | 9 | 62.50 | 19 | 14 | 79.17 | ||
N | 0.329 | 0.209 | |||||||
N0 | 99 | 65 | 34 | 65.66 | 27 | 72 | 27.27 | ||
N1 | 32 | 20 | 12 | 62.50 | 14 | 18 | 43.75 | ||
N2 | 34 | 18 | 17 | 52.94 | 12 | 23 | 35.29 | ||
T | 0.310 | 0.834 | |||||||
T1 | 4 | 1 | 3 | 25.00 | 2 | 2 | 50.00 | ||
T2 | 35 | 24 | 11 | 68.57 | 10 | 25 | 28.57 | ||
T3 | 110 | 69 | 41 | 62.73 | 36 | 74 | 32.73 | ||
T4 | 17 | 9 | 8 | 52.94 | 5 | 12 | 29.41 | ||
Stage | 0.666 | 0.646 | |||||||
I | 32 | 22 | 10 | 68.75 | 9 | 23 | 28.13 | ||
II | 64 | 41 | 23 | 64.06 | 18 | 46 | 28.13 | ||
III | 45 | 25 | 20 | 55.56 | 16 | 29 | 35.56 | ||
IV | 24 | 15 | 10 | 62.50 | 10 | 15 | 41.67 | ||
CEA | 0.338 | 0.887 | |||||||
<9.7 | 78 | 46 | 32 | 58.97 | 26 | 52 | 33.33 | ||
>9.7 | 24 | 13 | 11 | 54.17 | 8 | 16 | 33.33 | ||
NA | 64 | 44 | 20 | 68.75 | 19 | 45 | 29.69 |
Note:
Calculated χ2 test.
Abbreviations: CEA, carcinoembryonic antigen; CRC, colorectal cancer; M, methylated; PAX1, paired boxed gene 1; SOX1, sex-determining region Y-related high-mobility group box 1; TCGA, The Cancer Genome Atlas; U, unmethylated.